MoneyWorks4Me

Piramal Pharma - Quaterly Results

28 Jul 2025 Evaluate
A decrease in the sales to Rs. 9698.80 millions was observed for the quarter ended June 2025. The sales stood at Rs. 10632.00 millions during the similar quarter previous year.The company has announced a 32.68% increase in its profits to Rs . 1131.40  millions for the  quarter ended June 2025 compared to Rs. 852.70 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended June 2025 rose to 2252.50 millions as compared to 1883.90 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 9698.80 10632.00 -8.78 9698.80 10632.00 -8.78 52857.10 43901.10 20.40
Other Income 1809.20 367.60 392.17 1809.20 367.60 392.17 2073.50 2020.60 2.62
PBIDT 2252.50 1883.90 19.57 2252.50 1883.90 19.57 12477.90 8199.80 52.17
Interest 232.30 248.80 -6.63 232.30 248.80 -6.63 1145.60 1071.00 6.97
PBDT 2020.20 1635.10 23.55 2020.20 1635.10 23.55 11332.30 7128.80 58.97
Depreciation 594.40 518.50 14.64 594.40 518.50 14.64 2220.90 2052.60 8.20
PBT 1425.80 1116.60 27.69 1425.80 1116.60 27.69 9111.40 5076.20 79.49
TAX 294.40 263.90 11.56 294.40 263.90 11.56 2197.40 1164.00 88.78
Deferred Tax 98.10 -10.40 -1043.27 98.10 -10.40 -1043.27 203.00 39.20 417.86
PAT 1131.40 852.70 32.68 1131.40 852.70 32.68 6914.00 3912.20 76.73
Equity 13248.20 13229.50 0.14 13248.20 13229.50 0.14 13243.50 13229.50 0.11
PBIDTM(%) 23.22 17.72 31.07 23.22 17.72 31.07 23.61 18.68 26.39
Peers
Company Name CMP
Sun Pharma. Inds. 1846.00
Dr. Reddys Labs. 1229.40
Cipla 1390.60
Lupin 2071.00
Zydus Lifesciences 1216.25
View more..